ALUNBRIG emballage départ 7x90,21x180mg 28 pce

7680667380078 CH-66738 L01ED04 07.16.1.

Reimbursement limitations:

ALUNBRIG.02

Ligne de thérapie ultérieure (avec modèle de prix)
Après accord sur la prise en charge …

ALUNBRIG emballage départ 7x90,21x180mg 28 pce
ALUNBRIG emballage départ 7x90,21x180mg 28 pce
ALUNBRIG emballage départ 7x90,21x180mg 28 pce
1 / 3
google

Details

Product number
6673804
CPT
-
Packaging group
7 + 21
Unit
Tablette(n)
Composition
I) 90 mg: brigatinibum 90 mg, lactosum monohydricum 168.17 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.378 - 0.567 mg, silica hydrophobica colloidalis, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), E 171 pro compresso obducto. II) 180 mg: brigatinibum 180 mg, lactosum monohydricum 336.33 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.756 - 0.1134 mg, silica hydrophobica colloidalis, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), E 171 pro compresso obducto.

Articles (1)

Alunbrig 90 mg, 180 mg, Filmtabletten
Filmtabletten
7 + 21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/08/2025
Patient information leaflet
Français
12/08/2025
Patient information leaflet
Italien
12/08/2025
Professional SmPC
Allemand
12/08/2025
Professional SmPC
Français
12/08/2025
Professional SmPC
Italien
12/08/2025

Detailed composition

Substance Quantity Type Category
I
90.0 MG Substance Wirkstoff (Principe actif)
II
180.0 MG Substance Wirkstoff (Principe actif)
II
336.33 MG Substance HBESI
I
168.17 MG Substance HBESI
I
- Substance HNIDK
II
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
I
- Substance HBESI
II
- Substance HBESI
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance FNIDK
I
- Substance FNIDK

Reimbursement information

Public price
CHF 4730.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2021

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
66738
Drug name
Alunbrig, Filmtabletten
Galenic form
FILM
ATC Code
L01ED04
Authorization status
Z
Dispensation category
A
First authorization
04/05/2021
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
nicht-kleinzelliges Lungenkarzinom (NSCLC)

Packaging details

Description (FR)
ALUNBRIG emballage départ 7x90,21x180mg 28 pce
Description (DE)
ALUNBRIG Starterpackung 7x90,21x180mg 28 Stk
Market launch
04/05/2021
Narcotic (BTM)
No

Other packaging sizes

ALUNBRIG cpr pell 30 mg 28 pce
28 TABL
View
ALUNBRIG cpr pell 90 mg 7 pce
7 TABL
View
ALUNBRIG cpr pell 90 mg 28 pce
28 TABL
View
ALUNBRIG cpr pell 180 mg 28 pce
28 TABL
View